Comparison of perioperative and demographic variables among exceptional and poor responders ovarian cancer patients managed with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC)

Authors :: C. Velez-Mejia
Vadim Gushchin
Michelle Sittig
Ryan MacDonald
J.A. Ducie
Teresa Diaz-Montes
H.S. Ryu
Armando Sardi
Source :: Gynecologic Oncology. 154:143-144
Publication Year :: 2019
Publisher :: Elsevier BV, 2019.

Subjects :: medicine.medical_specialty
Oncology
business.industry
Poor responder
Obstetrics and Gynecology
Medicine
Hyperthermic intraperitoneal chemotherapy
Perioperative
Cytoreductive surgery
business
Ovarian cancer
medicine.disease
Surgery

Full Text Access

Tools